Penumbra Inc PEN

NYS: PEN | ISIN: US70975L1070 18:33

201,36 USD (-1,07%)

(-1,07%) 18:33

Grafiek Penumbra Inc

Grafiek Penumbra Inc

1 dag1d -1,07%
1 week1w -1,67%
1 maand1m -0,81%
3 maanden3m -25,04%
6 maanden6m -14,48%
1 jaar1j -36,81%
5 jaar5j 44,81%

Penumbra Inc in het nieuws

Toon enkel gratis nieuws

7 mei 2024 · Penumbra, Inc. Reports First Quarter 2024 Financial Results · Persbericht

1 mei 2024 · Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference · Persbericht

23 april 2024 · Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots · Persbericht

9 april 2024 · Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 · Persbericht

22 februari 2024 · Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results · Persbericht

1 februari 2024 · Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024 · Persbericht

19 december 2023 · Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference · Persbericht

10 november 2023 · Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans · Persbericht

2 november 2023 · Penumbra, Inc. Reports Third Quarter 2023 Financial Results · Persbericht

1 november 2023 · New Late Breaking Data Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy Technology For Pulmonary Embolism Improved Patient Outcomes · Persbericht

Profiel Penumbra Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.penumbrainc.com

Hoofdzetel: Alameda, California Verenigde Staten

CEO: Adam Elsesser

Werknemers: 2.391

Aandelen Penumbra Inc

Beurswaarde: 7,89 miljard USD

Effecten: 38,76 miljoen

Winst per aandeel (12 maand): PLUS

Koers-winstverhouding: PLUS

Beta: 1,26

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe